NEWTOWN, Pa., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced its participation in two investor conferences in February:
17th Annual BIO CEO & Investor Conference
Ramesh Kumar, Ph.D., President and CEO of Onconova will present a corporate update at 9:30 a.m. ET on Tuesday, February 10th at the Waldorf Astoria Hotel in New York City.
2015 Leerink Global Healthcare Conference
On Thursday, February 12th at 1:00 p.m. ET, Dr. Kumar will participate in a fireside chat presentation at the Waldorf Astoria Hotel in New York City.
These presentations will be webcast live and archived on the Company's website, www.onconova.com, on the Events & Presentations page under the Investors and Media tab.
About Onconova Therapeutics, Inc.
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and pre-clinical stage drug development candidates are derived from its proprietary chemical library and are designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. In addition to rigosertib, two other candidates, briciclib and recilisib, are clinical stage, and several candidates are in pre-clinical stages. For more information, please visithttp://www.onconova.com.
CONTACT: Onconova Therapeutics Benjamin Hoffman, 267-759-3036 Bhoffman@onconova.usSource:Onconova Therapeutics